You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

epcoritamab

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial (Epcoritamab)

Available
  • Lymphoma
  • Epcoritamab
  • (no location specified)
Jan 13, 2023

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

Not yet recruiting
  • Follicular Lymphoma
  • Low Grade Non-Hodgkin's Lymphoma, Adult
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

Not yet recruiting
  • Follicular Lymphoma
  • Biospecimen Collection
  • +7 more
  • Duarte, California
  • +1 more
Oct 27, 2023

CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

Not yet recruiting
  • CLL/SLL
  • Antwerpen, Belgium
  • +23 more
Mar 28, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

B-Cell Non-Hodgkin Lymphoma Trial in China (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Epcoritamab
  • +6 more
  • Beijing, Beijing, China
  • +20 more
May 31, 2022

DLBCL, Follicular Lymphoma Trial in United States (Epcoritamab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Epcoritamab
  • Fountain Valley, California
  • +38 more
Jul 27, 2022

Non Hodgkin Lymphoma Trial in Worldwide (Epcoritamab)

Recruiting
  • Non Hodgkin Lymphoma
  • Epcoritamab
  • Palo Alto, California
  • +44 more
Aug 12, 2022

DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
  • +7 more
  • Birmingham, Alabama
  • +61 more
Apr 13, 2022

Non-Hodgkin Lymphoma Trial in Worldwide (Epcoritamab, Lenalidomide, Ibrutinib)

Recruiting
  • Non-Hodgkin Lymphoma
  • Epcoritamab
  • +7 more
  • Tucson, Arizona
  • +81 more
Jan 25, 2023

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Epcoritamab
  • +10 more
  • Aberdeen, United Kingdom
  • +24 more
Apr 28, 2023

Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Epcoritamab
  • Investigator's Choice Chemotherapy
  • Irvine, California
  • +254 more
Jan 9, 2023

DLBCL Trial in Worldwide (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Epcoritamab
  • +5 more
  • Birmingham, Alabama
  • +376 more
Jan 30, 2023

Follicular Lymphoma (FL) Trial in Worldwide (Epcoritamab, Rituximab, Lenalidomide)

Recruiting
  • Follicular Lymphoma (FL)
  • Epcoritamab
  • +2 more
  • Tucson, Arizona
  • +281 more
Feb 1, 2023